Company Profile
Annovis Bio Stock Price, News & Analysis
- Ticker:
- ANVS
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.69 USD (+1.20%)
Close
Last updated: July 28, 2026
79.1M USD
Market cap
Why the stock is moving
As of Jul 28, 2026, ANVS closed up 1.20% at $1.69. No new same-company headline was identified in the current news window.
Company overview
Business overview
Annovis Bio is a neuroscience company focused on Alzheimer's disease and other neurodegenerative disorders. Its story is centered on high-risk CNS development and translational uncertainty.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Annovis sits in specialty neuroscience biotechnology.
Business Model Characteristics
The company depends on clinical validation, safety, and the ability to create a differentiated neurodegeneration franchise.
Position Within the Biotechnology Landscape
Annovis is a high-catalyst CNS name whose stock is highly sensitive to trial results and credibility.
Future catalysts
Annovis’s catalysts are buntanetap and the next CNS updates, especially in Alzheimer’s and Parkinson’s disease. The company remains highly sensitive to clinical readouts because the platform still needs validation.
Recent news
- 01
- 02
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
Source: Annovis Bio
- 03
Annovis Bio Regains NYSE Listing Compliance
Source: Annovis Bio
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Annovis Bio (ANVS)?
Annovis Bio (ANVS) most recently closed at 1.69 USD, a +1.20% move versus the previous session.
What is the market cap of Annovis Bio (ANVS)?
Annovis Bio currently has a market capitalization of 79.1M USD on BioPharmSignal.
What does Annovis Bio do?
Annovis Bio is a neuroscience company focused on Alzheimer's disease and other neurodegenerative disorders. Its story is centered on high-risk CNS development and translational uncertainty.
On which exchange is ANVS stock listed?
Annovis Bio (ANVS) is associated with NYSE, United States, Biopharma.
What is Annovis?
Annovis’s catalysts are buntanetap and the next CNS updates, especially in Alzheimer’s and Parkinson’s disease.
Which conditions is Annovis Bio targeting with Annovis?
Annovis Bio is associated with neuroscience based on its company overview and current catalyst commentary.
How does Annovis Bio describe recent progress with Annovis?
Annovis’s catalysts are buntanetap and the next CNS updates, especially in Alzheimer’s and Parkinson’s disease.
What is Alzheimer?
Annovis Bio is a neuroscience company focused on Alzheimer's disease and other neurodegenerative disorders.